Use of Generic Antiretroviral Agents and Cost Savings in PEPFAR Treatment Programs

JAMA - Journal of the American Medical Association - United States
doi 10.1001/jama.2010.993
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Medical Association (AMA)

Related search

The Cost of Providing Comprehensive HIV Treatment in PEPFAR-supported Programs

AIDS
Infectious DiseasesAllergyImmunology
2011English

Potential Savings From Greater Use of $4 Generic Drugs

Archives of Internal Medicine
2011English

Desimplification of Single Tablet Antiretroviral (ART) Regimens—A Practical Cost-Savings Strategy?

Journal of the International Association of Providers of AIDS Care
DermatologyInfectious DiseasesImmunology
2019English

Cost Savings by the Use of Bemiparin in the Treatment of Patients With Venous Thromboembolism in Spain

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Impact of Generic Alendronate Cost on the Cost-Effectiveness of Osteoporosis Screening and Treatment

PLoS ONE
Multidisciplinary
2012English

Cost Savings in Wastewater Treatment Processes: The Role of Environmental and Operational Drivers

Water Resources Management
CivilWater ScienceTechnologyStructural Engineering
2017English

Raltegravir in Combination With Other Antiretroviral Agents for the Treatment of HIV Infection

Infection and Drug Resistance
Infectious DiseasesPharmacology
2010English

Annual Energy Usage Reduction and Cost Savings of a School: End-Use Energy Analysis

The Scientific World Journal
BiochemistryMedicineGeneticsMolecular BiologyEnvironmental Science
2014English

Mobile Clinic in Massachusetts Associated With Cost Savings From Lowering Blood Pressure and Emergency Department Use

Health Affairs
MedicineHealth Policy
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy